Skip to content
Screener

EPS (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.27-0.9%
Stryker logo
StrykerSYK
$3.30+44.1%
PDE
Pro-Dex Inc.PDEX
$0.85+136%
CONMED logo
CONMEDCNMD
$0.77+11.6%
Vericel logo
VericelVCEL
$0.04+500%
Globus Medical logo
Globus MedicalGMED
$1.10-26.2%

Other financials

Income statement

See full
Revenue$2.2B+4.8%
Gross profit$1.5B+3.8%
Operating income$326.1M+8.7%
Net income$198.3M+29.8%

Balance sheet

See full
Cash & equivalents$410.0M-26.4%
Total debt$7.5B-1.2%
Total equity$12.6B+0.8%
Total assets$22.8B-0.3%

Cash flow

See full
Operating cash flow$447.8M+18.4%
CapEx$54.2M+8.2%
Free cash flow$393.6M+20.0%

Valuation

See full
Market cap$18.46B-6.7%
Enterprise value$25.53B-4.8%
P/E22.9×-1.2×
P/S2.2×-0.4×

Profitability

See full
Gross margin69.9%-1.2pp
Operating margin14.2%-1.9pp
Net margin9.5%-1.0pp
FCF margin17.9%-0.9pp

Returns & leverage

See full
Return on equity6.4%-0.1pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.2×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Zimmer Biomet Holdings’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335044
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Less: Net earnings attributable to noncontrolling interest1.30.61.51.1
Net Earnings of Zimmer Biomet Holdings, Inc.$198.3$152.8$436.5$334.9
Earnings Per Common Share
Basic$1.03$0.77$2.25$1.69
Diluted$1.03$0.77$2.25$1.68
Weighted Average Common Shares Outstanding
Basic192.2197.9193.6198.4
Diluted192.8198.3194.3199.0

Item 1. Financial Statements

FAQ

What is Zimmer Biomet Holdings's EPS (diluted)?
Zimmer Biomet Holdings (ZBH) reported EPS (diluted) of $1.03 in Q2 2026.
How has Zimmer Biomet Holdings's EPS (diluted) changed year-over-year?
Zimmer Biomet Holdings's EPS (diluted) increased by 33.8% year-over-year, from $0.77 to $1.03.
What is the long-term trend for Zimmer Biomet Holdings's EPS (diluted)?
Over 2 years (2023 to 2025), Zimmer Biomet Holdings's EPS (diluted) has grown at a -14.7% compound annual growth rate (CAGR), from $4.88 to $3.55.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Zimmer Biomet Holdings's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude